ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
62,735.19
-0.24%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Jazz Pharmaceuticals PLC (JAZZ)

  7. Jazz Pharmaceuticals PLC (JAZZ) Noticias

JAZZ Jazz Pharmaceuticals PLC

110.01
0.72 (0.66%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Jazz Pharmaceuticals PLC JAZZ NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.72 0.66% 110.01 17:45:55
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
110.14 108.58 111.55 110.01 109.29
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
01/5/202415:10PRNUSJazz Pharmaceuticals to Participate in the BofA Securities..
01/5/202415:05PRNUSJazz Pharmaceuticals Announces First Quarter 2024 Financial..
24/4/202415:05PRNUSJazz Pharmaceuticals to Present Data Across Growing Oncology..
17/4/202415:15PRNUSJazz Pharmaceuticals to Report 2024 First Quarter Financial..
10/4/202406:45PRNUSJazz Pharmaceuticals to Showcase Expansive Neuroscience..
02/4/202406:30PRNUSJazz Pharmaceuticals Completes Zanidatamab Biologics License..
12/3/202415:15PRNUSJazz Pharmaceuticals to Host Virtual Zanidatamab R&D Day on..
08/3/202417:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202420:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202420:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202420:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202420:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202417:09EDGAR2Form 144 - Report of proposed sale of securities
05/3/202418:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202418:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202418:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202418:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202418:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202418:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202418:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202418:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202418:14EDGAR2Form 3 - Initial statement of beneficial ownership of..
01/3/202414:11EDGAR2Form 144 - Report of proposed sale of securities
28/2/202415:06EDGAR2Form 8-K - Current report
28/2/202415:05PRNUSJazz Pharmaceuticals Announces Full Year and Fourth Quarter..
27/2/202406:45EDGAR2Form 8-K - Current report
27/2/202406:45PRNUSJazz Pharmaceuticals Appoints Patrick Kennedy to its Board..
21/2/202406:46EDGAR2Form 8-K - Current report
21/2/202406:45PRNUSJazz Pharmaceuticals Appoints Philip Johnson as Chief..
20/2/202415:15PRNUSJazz Pharmaceuticals to Participate in Upcoming March..
14/2/202415:15PRNUSJazz Pharmaceuticals to Report 2023 Full Year and Fourth..
07/2/202401:00PRNUSJazz Pharmaceuticals Enters Definitive Agreement with Redx..
25/1/202416:01EDGAR2Form 8-K - Current report
24/1/202408:46EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
19/1/202417:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202417:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202417:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202417:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202417:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202406:45EDGAR2Form 8-K - Current report
21/12/202315:05PRNUSJazz Pharmaceuticals Provides Update on Phase 2 Trial of..
20/12/202315:15PRNUSJazz Pharmaceuticals to Present at the 42nd Annual J.P...
15/12/202306:45EDGAR2Form 8-K - Current report
08/12/202312:20PRNUSJazz Pharmaceuticals Presents Updated Phase 2a Data at SABCS..
06/12/202315:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202315:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202308:02PRNUSJazz Pharmaceuticals to Present Long-Term and Real-World..
30/11/202306:45PRNUSJazz Pharmaceuticals to Present New Data Highlighting..
14/11/202301:00BWAutifony Announces Exclusive Global License and..
08/11/202315:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Su Consulta Reciente

NASDAQ
JAZZ
Jazz Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados